Skip to content
MarketNewsAPI
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
AXON$422.00+7.40(+1.78%)Axon Announces Body 5: Next-Generation Camera Built for the AI Era Axon (Nasdaq: AXON), the global leader in public safety technology, today announced Axon Body 5, its newest body-worn camera designed to bring more...[1:00:00 PM ET]PFE$30.02-0.40(-1.31%)Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026[11:18:00 AM ET]BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]

APPN · NASDAQ

Appian Corporation

$52.35 +1.04 (+2.03%)

Company overview

Appian Corporation provides a low-code automation platform in the United States and internationally. The company's platform automates the creation of forms, workflows, data structures, reports, user interfaces, and other software elements that would otherwise need to be manually coded. The company also offers professional and customer support services. It serves the financial services, government, life sciences, insurance, manufacturing, energy, healthcare, telecommunications, and transportation industries. The company was incorporated in 1999 and is headquartered in McLean, Virginia.

Sector
Technology
Industry
Software - Application
Exchange
NASDAQ
Market cap
$3.7B
Employees
2,033
Headquarters
McLean, VA
Website
appian.com
CEO
Matthew W. Calkins
Listed
May 25, 2017
P/E
3,313.29
Dividend yield
0.00%

Company financials

Revenue
$763M
Gross profit
$563M
Operating income
$4.6M
EBITDA
$32.8M
Net income
$885,000
EPS
$0.02
Total assets
$623M
Total debt
$286M
Gross margin
73.84%
Net margin
0.12%
Earnings yield
0.03%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

17.2126.7936.3845.9655.54
APPN 1D NASDAQ O50.66H54.12L50.66C52.35+1.20 (+2.35%)Vol1.49M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
APPN Stock news Why Appian Stock Surged 24.2% This Week The Motley Fool
APPN Stock news Is Appian Corp (APPN) a Bargain After 6.0% Drop? GF Value Says Undervalued GuruFocus
APPN Press release Appian To Announce Third Quarter 2026 Financial Results on November 5, 2026 GlobeNewswire
APPN Stock news Appian (NASDAQ:APPN) CEO Sells $1,687,500.00 in Stock Defense World
APPN Stock news Appian (NASDAQ: APPN) CEO sells shares under trading plan Defense World
APPN Stock news Appian (NASDAQ:APPN) Shares Up 6.4% – What’s Next? Defense World
APPN Stock news Is It Too Late to Buy Appian Corp (APPN) After 7.1% Rally? GF Value Says Undervalued GuruFocus
APPN Stock news Virginia Business Names Appian Chief People Officer Susan Charnaux a 2026 Women in Leadership Awards Recipient GuruFocus
APPN Press release Virginia Business Names Appian Chief People Officer Susan Charnaux a 2026 Women in Leadership Awards Recipient PR Newswire
APPN Press release El informe Gartner® 2026 sitúa a Appian en el primer puesto en flujos de trabajo y consolidación de plataformas PR Newswire
APPN Press release Le rapport Critical Capabilities™ 2026 de Gartner® consacré aux technologies d'orchestration et d'automatisation des processus métier classe Appian n° 1 pour les cas d'utilisation « Automatisation déterministe des flux de travail » et « Con. PR Newswire
APPN Press release Appian domina la classifica nel report Gartner® Critical Capabilities™ 2026 sulle tecnologie di orchestrazione e automazione aziendale, per i casi d'uso relativi all'automazione deterministica dei flussi di lavoro e al consolidamento delle . PR Newswire
APPN Press release Appian belegt Platz 1 im 2026 Gartner® Critical Capabilities™ for Business Orchestration and Automation Technologies Report bei den Anwendungsfällen „Deterministische Workflow-Automatisierung" und „Plattformkonsolidierung" PR Newswire
APPN Stock news Appian Corp (APPN) Shares Fall 4.5% -- What GF Score of 78 Tells Investors GuruFocus
APPN Press release 2026 Gartner® Critical Capabilities™ for Business Orchestration and Automation Technologies Report Ranks Appian #1 for the Deterministic Workflow Automation Use Case and Platform Consolidation Use Case PR Newswire
APPN Stock news Best Momentum Stocks to Buy for September 15th Zacks Investment Research
APPN Stock news Appian Corporation (APPN) Presents at Citi's 2026 Global TMT Conference Transcript Seeking Alpha
APPN Press release Appian CFO to Present at Citi’s Global TMT Conference GlobeNewswire
APPN Stock news Brokerages Set Appian Corporation (NASDAQ:APPN) Price Target at $31.00 Defense World
APPN Stock news Appian: Proving Itself As An Essential AI Layer With Accelerating Growth Seeking Alpha
See more
FAQ

Questions about Appian Corporation

What does Appian Corporation do?
Appian Corporation provides a low-code automation platform in the United States and internationally. The company's platform automates the creation of forms, workflows, data structures, reports, user interfaces, and other software elements that would otherwise need to be manually coded. The company also offers professional and customer support services. It serves the financial services, government, life sciences, insurance, manufacturing, energy, healthcare, telecommunications, and transportation industries. The company was incorporated in 1999 and is headquartered in McLean, Virginia.
What is APPN's market cap?
Appian Corporation (APPN) is a listed stock with a live quote. The latest market cap on this page is $3.7B.
Where is Appian Corporation headquartered?
Appian Corporation is headquartered in McLean, VA.
How do I get APPN news from the API?
Call GET /v1/news?tickers=APPN. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does APPN news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for APPN, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the APPN price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 2,000 REST requests a day. Paid Pro removes the daily cap. If you don't subscribe, the account stays on Free.

Start 7-day free trial Read the docs